Tag Archives: Zontivity

FDA approves Zontivity to reduce risk of heart attacks and stroke in high-risk patients

Washington: The US Food and Drug Administration has approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart attack or blockages in the arteries to the legs.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment